...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing
【24h】

Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing

机译:Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing

获取原文
获取原文并翻译 | 示例
           

摘要

The protein kinase TNK2 (ACK1) is an emerging drug target for a variety of indications, in particular for cancer where it plays a key role transmitting cell survival, growth and proliferative signals via modification of multiple downstream effectors by unique tyrosine phosphorylation events. Scaffold morphing based on our previous TNK2 inhibitor XMD8-87 identified urea 17 from which we developed the potent and selective compound 32. A co-crystal structure was obtained showing 32 interacting primarily with the main chain atoms of an alanine residue of the hinge region. Additional H-bonds exist between the urea NHs and the Thr205 and Asp270 residues.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号